In our fourth month of the virtualization of everything, we continue to admire the resilience of our many entrepreneurs and the determination of investors to support women-led companies in these uncertain times. Many organizations are gratified by their ability to adapt and continue on course. Golden Seeds is no exception.
A recent highlight is the recognition of Cognition Therapeutics with a $75.8 million landmark grant for an Alzheimer’s clinical trial. It is a testament to the groundbreaking research being done at Cognition Therapeutics. Read below a conversation with Co-Founder and Chief Science Officer Dr. Susan Catalano and CEO Lisa Ricciardi. Congratulations to this remarkable team.
Many boards of directors have been playing multiple roles to support companies during this challenging time. Golden Seeds Fund Partners Deb Kemper and Kathryn Swintek share their views of many years of board experience in the blog below. And two Golden Seeds Managing Partners, Susan Nethero and David Nethero, founders of our Atlanta chapter, provide advice to entrepreneurs who were planning to launch before COVID changed so much.
We are proud to share three recent blogs about Golden Seeds companies. Hello Alice, a Houston company, is matching small businesses with personalized opportunities and resources. Kinnos, of Brooklyn, is focused on effective disinfection of surfaces. And CNote, is an Oakland company that provides fixed-income opportunities that support Main Street America – focused on female and minority entrepreneurs.
Wishing you good health in this difficult time.